MedPath

The effect of ingestion of fucoidan derived from Cladosiphon okamuranus on human NK cells.

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000043804
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Persons who have a serious disease, are undergoing treatment, have a medical history 2)Persons who have a chronic disease and regularly use drugs 3)Persons who regularly use supplements/health foods (including foods for specified health use and foods with functional claims) that may affect immunity 4)Persons who constantly drink more than proper drinking (500 mL per bottle of beer on average per day) 5)Persons who cannot stop drinking from 2 days before each test 6)Persons who have been declared to have allergies 7)Persons with a history of gastrointestinal diseases and gastrointestinal surgery 8)Persons who participants in trials using other foods, medicines and cosmetics 9)Persons who are pregnant, willing to become pregnant during the test period, or breastfeeding 10)Person who the doctor responsible for the study deems inappropriate as a subject

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of NK cell activity (from the start of ingestion to 12 weeks later)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath